-
High-Intensity Surveillance of Colorectal Adenomas Modeled
drugs
September 24, 2019
For patients with colorectal adenomas, high-intensity surveillance could provide modest benefits over low-intensity surveillance, at an acceptable cost, according to a study published online in the Annals of Internal Medicine.
-
Colorectal Cancer Mortality Disparities Vary Across U.S. Cities
drugs
September 23, 2019
There is considerable variability in colorectal cancer (CRC) mortality disparities across urban cities...
-
Incidence of Colorectal Cancer Up in Younger Adults Worldwide
drugs
September 09, 2019
Among younger adults, colorectal cancer (CRC) incidence rates have increased in several countries, according to a study published online in Gut.
-
Oral Antibiotic Use Linked to Risk for Colorectal Cancer
drugs
August 22, 2019
Oral antibiotic use is associated with an increased risk for colon cancer and a reduced risk for rectal cancer, according to a study published online in Gut.
-
Younger CRC Patients More Likely to Present With Abdominal Pain
drugs
August 09, 2019
Younger patients with colorectal cancer are more likely to present with abdominal pain and via an emergency, according to a study published online in Colorectal Disease.
-
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement
worldpharmanews
July 19, 2019
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement.
-
Bayer, BMS, Ono to Collaborate on Colorectal Cancer Treatments
contractpharma
July 19, 2019
Aims to evaluate the combination of Bayer's Stivarga and BMS / Ono's Opdivo in patients with MSS mCRC.
-
Colonoscopy Rates Increased in Those Aged 45 to 54 Years
drugs
July 17, 2019
From 2000 to 2015, colonoscopy rates increased among those aged 45 to 54 years, while colorectal cancer incidence increased among those aged 40 to 54 years...
-
Novel colorectal cancer vaccine shows positive phase I results
europeanpharmaceuticalreview
May 05, 2019
A new vaccine for colorectal cancer has proven to be safe in a small sample of human subjects, opening the way for the next phase of testing.
-
Some Patients With Imminently Fatal Cancer Undergo Treatment
drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.